Reaction #61098

ord-aaed209479704dfface6349d9138a5dc

Conditions

Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    Otherpartitioned between ethyl acetate and water
  2. 2
    OtherThe organic layer was separated
  3. 3
    Dryingdried over sodium sulfate
  4. 4
    Filtrationfiltered
  5. 5
    Concentrationconcentrated in vacuo
  6. 6
    OtherThe residue was purified by chromatography over silica gel
  7. 7
    Washeluted first with ethyl acetate
  8. 8
    Washgradient eluted with dichloromethane containing from 0 to 10% methanol
  9. 9
    OtherPrecipitation of the isolated product from dichloromethane with an excess of hexanes

Procedure

Crude (2S,3S)-2-{(R)-2-amino-2-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-acetylamino}-3-phenyl-N-(4-propionyl-thiazol-2-yl)-butyramide (≈0.16 mmol) was dissolved in tetrahydrofuran (10 mL) that contained diisopropylethylamine (142 μL, 105 mg, 0.81 mmol) and was transferred via cannula to a solution of diphosgene (14 μL, 23 mg, 0.12 mmol) in tetrahydrofuran (15 mL) at 0° C. The reaction mixture was stirred for 20 minutes and then partitioned between ethyl acetate and water. The organic layer was separated and dried over sodium sulfate, filtered and concentrated in vacuo. The residue was purified by chromatography over silica gel eluted first with ethyl acetate and then gradient eluted with dichloromethane containing from 0 to 10% methanol. Precipitation of the isolated product from dichloromethane with an excess of hexanes gave (2S,3S)-2-{2,5-dioxo-4-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-1-yl}-3-phenyl-N-(4-propionyl-thiazol-2-yl)-butyramide as a white solid (26 mg, 27%).

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07427635B2uspto-grants-2008_09